Clinical trial

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

NCT06435156

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Sotagliflozin Normalized identity: sotagliflozinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-01-28

PhasePHASE2

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Heart Failureverified · MONDO: heart failure

Interventions

SotagliflozinDRUG · verified · RxNorm: sotagliflozin

PlaceboDRUG

Sponsors & collaborators

University of Dundeelead sponsor

Lexicon Pharmaceuticalscollaborator

Juvenile Diabetes Research Foundationcollaborator

Mapped research locations

ManchesterUnited Kingdom4 LondonUnited Kingdom2 GlasgowUnited Kingdom1 CambridgeUnited Kingdom1 SheffieldUnited Kingdom1 LiverpoolUnited Kingdom1 EdinburghUnited Kingdom1 LeicesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06435156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.